The store will not work correctly when cookies are disabled.
2-(8-hydroxyquinolin-2-yl)-3-(4-methoxyphenyl)thiazolidin-4-one
ID: ALA4752621
PubChem CID: 162652664
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)cc1
Standard InChI: InChI=1S/C19H16N2O3S/c1-24-14-8-6-13(7-9-14)21-17(23)11-25-19(21)15-10-5-12-3-2-4-16(22)18(12)20-15/h2-10,19,22H,11H2,1H3
Standard InChI Key: MTQUXKDZDDTRIK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.8175 -9.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8163 -10.6382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5244 -11.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5226 -9.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2312 -9.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2320 -10.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9405 -11.0411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6488 -10.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6440 -9.8082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9349 -9.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5263 -11.8643 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3622 -11.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4508 -11.8457 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2508 -12.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6567 -11.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1074 -10.6981 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8473 -12.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0685 -12.1412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4637 -12.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6365 -13.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4195 -13.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0209 -13.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5861 -12.7577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0320 -14.0392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2535 -13.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
20 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.42 | Molecular Weight (Monoisotopic): 352.0882 | AlogP: 3.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 3.11 | CX LogD: 3.10 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.78 | Np Likeness Score: -0.66 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |